Genworth Holdings, Inc. sold $45.2M of ACT
Genworth Holdings, Inc. sold 990,583 shares of Enact Holdings, Inc. (ACT) at $45.62 ($45.19M total) on 2026-11-03.
Enact Holdings, Inc.
Enact is a private mortgage insurer serving the United States housing finance market. It writes and assumes residential mortgage guaranty insurance, primarily covering individual low down payment loans and protecting lenders and investors against certain losses from borrower nonpayment. Its customers are mortgage lenders, including banks, non-bank lenders, mortgage bankers and credit unions. Enact operates mainly through Enact Mortgage Insurance Corporation, an insurer approved by Fannie Mae and Freddie Mac. Enact’s main product is primary mortgage insurance, with coverage and premiums set for each insured loan; it also offers pool mortgage insurance and a separate policy through Enact Mortgage Insurance Corporation of North Carolina for loans and portfolios not intended for sale to the government-sponsored enterprises. The company also provides fee-based contract underwriting services and mortgage and credit-related insurance and reinsurance through subsidiaries. It earns premiums for insurance coverage and fees for underwriting services. Enact is headquartered in Raleigh, North Carolina.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $ACT in the last 7 days.
Genworth Holdings, Inc. sold 990,583 shares of Enact Holdings, Inc. (ACT) at $45.62 ($45.19M total) on 2026-11-03.
Enact Holdings (ACT) declared a $0.24 per share quarterly dividend, matching its previous payout. The forward yield is 1.99%. The dividend is payable on December 17 to shareholders of record on November 25, with an ex-dividend date of November 25.
Enact Holdings, Inc. (ACT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ENACT REPORTS THIRD QUARTER 2026 RESULTS; ANNOUNCES $0.24 QUARTERLY DIVIDEND _______________________________________ GAAP Net Income of $159 million, or $1.15 per diluted share Adjusted Operating Income of $164 million, or $1.19 per diluted share Return on Equity of
Recent ACT coverage spans financial news, corporate actions and earnings.
In the last 30 days, ACT insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($45.2M). The most active reporter was Genworth Holdings, Inc. with 1 filing.
Large insider sell may signal negative sentiment for Enact and could pressure the stock.
Dividend declaration may attract income‑focused investors and provide modest price support.
Earnings beat prior quarter and guidance increase may support modest upside.
Earnings beat on net income and new capital return guidance may boost the stock.
Downgrade tied to housing-policy automation risk likely pressures valuation expectations for ACT.
AlphAI scores every news story that mentions ACT with an AI model for sentiment and relevance, and aggregates insider trades from Enact Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Genworth Holdings, Inc. sold 990,583 shares of Enact Holdings, Inc. (ACT) at $45.62 ($45.19M total) on 2026-11-03.
Enact Holdings (ACT) declared a $0.24 per share quarterly dividend, matching its previous payout. The forward yield is 1.99%. The dividend is payable on December 17 to shareholders of record on November 25, with an ex-dividend date of November 25.
Enact Holdings, Inc. (ACT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ENACT REPORTS THIRD QUARTER 2026 RESULTS; ANNOUNCES $0.24 QUARTERLY DIVIDEND _______________________________________ GAAP Net Income of $159 million, or $1.15 per diluted share Adjusted Operating Income of $164 million, or $1.19 per diluted share Return on Equity of
Enact Holdings (ACT) reported Q3 2026 net income of $159M, down from Q2 2026. New insurance written was $14B, with primary insurance in-force at $275B. The company anticipates $600M in 2026 shareholder returns, subject to performance and market conditions. ACT repurchased $175M in shares and declared a $0.24 dividend.
BofA Securities downgraded Enact, Essent, and NMI Holdings due to regulatory risks, causing their shares to drop. The White House's executive order may impact mortgage insurance policies. BofA cut price targets for all three companies, citing valuation concerns.
Enact Holdings director Thomas J. McInerney will resign from the board and Compensation Committee on December 31, 2026. The company stated this is not due to any dispute or disagreement with its operations, policies, or practices.
Enact Holdings, Inc. (ACT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 29, 2026, Thomas J. McInerney advised Enact Holdings, Inc. (the “Company”) and the Company’s Board of Directors
BofA Securities downgraded Enact Holdings (NASDAQ:ACT) to Underperform, lowering its price target to $42.00 from $53.00 due to housing policy concerns and soft sector growth. The stock trades at $48.06, above the new target. Enact's revenue grew 2.5% over the last year. Other mortgage insurers were also downgraded or kept at Underperform.
RBC Capital maintained a Hold rating on Enact Holdings (ACT) with a $50.00 price target. Shares closed at $44.90. J.P. Morgan downgraded ACT to Sell. Q2 revenue was $317.31M, net profit $174.84M. Insider sentiment is negative, with recent sales by executives.
JPMorgan downgraded Enact Holdings (ACT) to Underweight, lowering its price target to $44.00. The stock trades at $45.97, above the target and fair value estimates, suggesting overvaluation. JPMorgan cited premium valuation and mixed effects from higher interest rates. Enact reported Q2 2026 earnings beating estimates, with $1.26 EPS and $317.3M revenue. BTIG initiated coverage with a Neutral rating, noting expected ROE declines.